The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials Xianbin YuJinwu WangWenhao Zheng ReviewPaper 04 January 2020 Pages: 243 - 257
Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life Azza A. TantawyNayera H. K. ElsherifMarwa E. Kabil OriginalPaper 19 January 2020 Pages: 258 - 266
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE Jeffrey I. WeitzSylvia Haasthe GARFIELD-VTE investigators OriginalPaper 24 June 2020 Pages: 267 - 277
Pulmonary intravascular coagulation in COVID-19: possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy F. Burcu Belen-ApakF. Sarıalioğlu Letter to the Editor 05 May 2020 Pages: 278 - 280
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia Vittorio PavoniLara GianeselloFrancesca Covani Frigieri OriginalPaper 11 May 2020 Pages: 281 - 286
Heparin resistance in COVID-19 patients in the intensive care unit D. WhiteS. MacDonaldW. Thomas OriginalPaper 22 May 2020 Pages: 287 - 291
Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia Bingwen Eugene FanYew Woon ChiaJensen Ng Letter to the Editor 30 May 2020 Pages: 292 - 297
The association between treatment with heparin and survival in patients with Covid-19 Luis AyerbeCarlos RiscoSalma Ayis BriefCommunication Open access 31 May 2020 Pages: 298 - 301
Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients Anna BetouleCamille MartinetAurélien Renard BriefCommunication 05 June 2020 Pages: 302 - 304
Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials Natale Daniele BrunettiLucia TricaricoMatteo Di Biase ReviewPaper 25 October 2019 Pages: 305 - 310
Non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis Yunguo ZhouWenfeng HeWengen Zhu ReviewPaper 02 December 2019 Pages: 311 - 317
Deep vein thrombosis: a less noticed complication in hematologic malignancies and immunologic disorders Hassan AlipanahzadehReza GhulamrezaMohsen Maleknia ReviewPaper 05 December 2019 Pages: 318 - 329
Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment Maura J. JonesSarah T. EudaleyAndrea S. Franks OriginalPaper 04 January 2020 Pages: 330 - 336
Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials Monica VerdoiaElvin KedhiGiuseppe De Luca OriginalPaper 09 January 2020 Pages: 337 - 354
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience Angelo PorfidiaFabiana AgostiniRoberto Pola OriginalPaper 01 February 2020 Pages: 355 - 360
Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats Naif O. Al-HarbiFaisal ImamKhalid Saad Alharbi OriginalPaper 01 May 2020 Pages: 361 - 370
Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban Ei-ichi UenoKosuke FujibayashiKouji Kajinami OriginalPaper 12 March 2020 Pages: 371 - 379
Soluble platelet endothelial cell adhesion molecule 1 (sPECAM-1) improves diagnostic accuracy of D-Dimer in patients with suspected deep vein thrombosis (DVT) Joerg KellermairAlexander FellnerClemens Steinwender OriginalPaper Open access 26 March 2020 Pages: 380 - 385
Inpatient and outpatient treatment patterns of cancer-associated thrombosis in the United States J. D. GuoP. HlavacekL. Rosenblatt OriginalPaper Open access 18 January 2020 Pages: 386 - 394
Antithrombotic therapy for atrial fibrillation with stable coronary artery disease: a meta-analysis of randomized controlled trials Babikir KheiriTimothy F. SimpsonJoaquin E. Cigarroa BriefCommunication 24 January 2020 Pages: 395 - 398
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience Jason FilopeiEric E. BondarskyDavid J. Steiger OriginalPaper 29 January 2020 Pages: 399 - 407
Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study Eser DurmazBilgehan KaradagZeki Ongen OriginalPaper 13 April 2020 Pages: 408 - 415
Superficial venous thrombosis: is it as benign as we think? B. LuiP. HoH. Y. Lim Letter to the Editor 13 February 2020 Pages: 416 - 420
Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation Christina YipAruni SeneviratnaMark Y. Chan OriginalPaper 19 February 2020 Pages: 421 - 429
ABO blood group influences risk of venous thromboembolism and myocardial infarction Hui PangZhenkun ZongQiumei Cao OriginalPaper 09 December 2019 Pages: 430 - 438
Blood type association with bleeding outcomes at delivery in a large multi-center study Najeebah A. BadeJamil M. KazmaHoma K. Ahmadzia OriginalPaper 19 December 2019 Pages: 439 - 445
Comparison of 2013 and 2009 versions of Caprini risk assessment models for predicting VTE in Chinese cancer patients: a retrospective study Mei-Mei ShangRong YanZhen-Qing Guo OriginalPaper 23 January 2020 Pages: 446 - 451
Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy Kristin R. SmithWilliam E. Bryan IIIJamie N. Brown OriginalPaper 02 January 2020 Pages: 452 - 456
Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes Kyle A. DavisJoel JosephSarah A. Nisly OriginalPaper 08 January 2020 Pages: 457 - 461
Baseline thrombocytopenia in women with coronary heart disease increases incident acute coronary syndrome: insights from national inpatient database Sharan P. SharmaRahul ChaudharyAshok Kondur OriginalPaper 06 April 2020 Pages: 462 - 467
Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel Plinio CirilloVittorio TaglialatelaGiovanni Cimmino BriefCommunication 25 April 2020 Pages: 468 - 472
An unusual presentation of Idiopathic hypereosinophilic syndrome Chun En ChuaVictor LingBenjamin Yong-Qiang Tan Letter to the Editor 06 May 2020 Pages: 473 - 476
Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines Angelo PorfidiaRoberto Pola Correction 16 May 2020 Pages: 477 - 477
Correction to: Heparin resistance in COVID‑19 patients in the intensive care unit D. WhiteS. MacDonaldW. Thomas Correction 22 June 2020 Pages: 478 - 478